PH

	Researchers develop blood-brain-barrier-permeable nanoparticles for Alzheimer's disease treatment [23-08-2022] Alzheimer´s disease (AD) is a complex neurodegenerative disease that leads to insidious deterioration of brain functions. Current treatments for AD that focus on inhibition of amyloid beta (Aβ) aggregation failed to show effectiveness in people with AD symptoms.

Related News

	ICN2 Spin-off INBRAIN Neuroelectronics Achieves the World´s First Application of a Graphene Brain-Computer Interface in a Human Patient [27-09-2024] Nanomedicine, Graphene

	A nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment [01-02-2024] Nanomedicine

	Metal-free graphene quantum dots show promise for highly efficient tumor therapy [12-01-2024] Nanomedicine, Graphene, Quantum Science

	Using AI, researchers identify a new class of antibiotic candidates that can kill a drug-resistant bacterium [20-12-2023] Nanobiotechnology, Nanomedicine, Artificial intelligence

	Researchers propose new strategy to improve efficiency for nanotherapeutic delivery in tumors [23-10-2023] Nanomedicine

CLOSE

© Phantoms Foundation 2024